Skip to main navigation Skip to search Skip to main content

Identification of Potential Biomarkers for CAD Using Integrated Expression and Methylation Data

  • Xiaokang Zhang
  • , Yang Xiang
  • , Dingdong He
  • , Bin Liang
  • , Chen Wang
  • , Jing Luo
  • , Fang Zheng*
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

DNA methylation plays an essential role in the pathogenesis of coronary artery disease (CAD) through regulating mRNA expressions. This study aimed to identify hub genes regulated by DNA methylation as biomarkers of CAD. Gene expression and methylation datasets of peripheral blood leukocytes (PBLs) of CAD were downloaded from the Gene Expression Omnibus (GEO) database. Subsequently, multiple computational approaches were performed to analyze the regulatory networks and to recognize hub genes. Finally, top hub genes were verified in a case-control study, based on their differential expressions and methylation levels between CAD cases and controls. In total, 535 differentially expressed-methylated genes (DEMGs) were identified and partitioned into 4 subgroups. TSS200 and 5 ' UTR were confirmed as high enrichment areas of differentially methylated CpGs sites (DMCs). The function of DEMGs is enriched in processes of histone H3-K27 methylation, regulation of post-transcription and DNA-directed RNA polymerase activity. Pathway enrichment showed DEMGs participated in the VEGF signaling pathway, adipocytokine signaling pathway, and PI3K-Akt signaling pathway. Besides, expressions of hub genes fibronectin 1 (FN1), phosphatase (PTEN), and tensin homolog and RNA polymerase III subunit A (POLR3A) were discordantly expressed between CAD patients and controls and related with DNA methylation levels. In conclusion, our study identified the potential biomarkers of PBLs for CAD, in which FN1, PTEN, and POLR3A were confirmed.
Original languageEnglish
Article number778
Number of pages18
JournalFRONTIERS IN GENETICS
Volume11
DOIs
StatePublished - 9 Sep 2020

Funding

This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81871722) and the Science, Technology and Innovation Seed Fund of Wuhan University Zhongnan Hospital (Grant Nos. znpy2019054 and znpy2019049).

Keywords

  • coronary artery disease
  • methylation
  • FN1
  • PTEN
  • POLR3A

Indexed by

  • SCIE
  • Scopus

Fingerprint

Dive into the research topics of 'Identification of Potential Biomarkers for CAD Using Integrated Expression and Methylation Data'. Together they form a unique fingerprint.

Cite this